Keywords: growth, forecasts, antidepressant, drugs, sales, serotonin, reuptake
Growth Forecasts For Antidepressant Drugs
Article | 08 May 1995
Sales of three serotonin reuptake inhibitor antidepressants, Eli Lilly's Prozac (fluoxetine), SmithKline Beecham's Seroxat/Paxil (paroxetine) and Pfizer's Zoloft (sertraline), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
